B. Wengle

发表

Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study.

L. Lind, S. Ljunghall, L. Wide, 1989, American journal of hypertension.

Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study.

L. Lind, S. Ljunghall, L. Wide, 1988, American journal of hypertension.

Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease.

L. Lind, H. Lithell, S. Ljunghall, 1988, BMJ.

Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study.

L. Lind, S. Ljunghall, B. Wengle, 2009, Acta medica Scandinavica.

Plasma ionized calcium and cardiovascular risk factors in mild primary hyperparathyroidism: effects of long‐term treatment with active vitamin D (Alphacalcidol)

L. Lind, H. Lithell, S. Ljunghall, 1992, Journal of internal medicine.

No major metabolic alterations accompany the hypotensive effect of active vitamin D.

L. Lind, H. Lithell, S. Ljunghall, 1991, Upsala journal of medical sciences.

Blood pressure in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening programme

K. Hellström, T. Christensson, B. Wengle, 1977, European journal of clinical investigation.

Volatile phenols in serum of uraemic patients.

K. Hellström, B. Wengle, 1972, Clinical science.

A gas chromatographic technique for the analysis of volatile phenols in serum.

K. Hellström, B. Wengle, 1971, Scandinavian journal of clinical and laboratory investigation.

Cardiovascular risk factors in primary hyperparathyroidism: a 15‐year follow‐up of operated and unoperated cases

L. Lind, H. Lithell, S. Ljunghall, 1991, Journal of internal medicine.

Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism.

L. Lind, G. Åkerström, S. Ljunghall, 1989, Acta endocrinologica.

Clinical and Laboratory Findings in Subjects with Hypercalcaemia

K. Hellström, T. Christensson, B. Wengle, 2009 .

Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals.

L. Lind, H. Lithell, S. Ljunghall, 1991, Scandinavian journal of urology and nephrology.

A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure.

L. Lind, H. Lithell, S. Ljunghall, 1988, Scandinavian journal of urology and nephrology.

Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in a health screen.

K. Hellström, T. Christensson, B. Wengle, 1977, Archives of internal medicine.

Prevalence of hypercalcaemia in a health screening in Stockholm.

K. Hellström, A. Alveryd, T. Christensson, 2009, Acta medica Scandinavica.

Suppression of serum parathyroid hormone levels by intravenous alphacalcidol in uremic patients on maintenance hemodialysis. A pilot study.

L. Lind, S. Ljunghall, L. Wide, 1988, Nephron.

Diagnosis of malignant lymphoma at laparotomy disclosing intrahepatic cholestasis.

K. Hellström, H. Nordenstam, C. Groth, 1972, Acta chirurgica Scandinavica.

Letter: Chronic active hepatitis induced by nitrofurantoin.

B. Wengle, A. Strömberg, 1976, British medical journal.

Transient cholestasis during treatment with ajmaline, and chronic xanthomatous cholestasis after administration of ajmaline, methyltestosterone and ethinylestradiol. Two case reports.

K. Hellström, B. Beermann, J. Ericsson, 2009, Acta medica Scandinavica.

Serum levels of 1,25-(OH)2-vitamin D are not altered by long-term supplementation with alphacalcidol (1-OH-vitamin D3). A double-blind, placebo-controlled study.

L. Lind, S. Ljunghall, B. Wengle, 2009, Experimental and clinical endocrinology.

Delayed Hypersensitivity in Primary and Secondary Hyperparathyroidism. Treatment with Active Vitamin D

L. Lind, S. Ljunghall, B. Wengle, 1990, Experimental and clinical endocrinology.

Clinical and laboratory findings in subjects with hypercalcaemia. A study including cases with primary hyperparathyroidism detected in a health screening.

K. Hellström, T. Christensson, B. Wengle, 1976, Acta medica Scandinavica.